valsartan / Generic mfg. |
ChiCTR-IOR-16008847: Clinical Study of Huangqi Decoction/Astragalus Decoction in the Treatment of 'Qi-Yin Vital Essence Deficiency' Type DKD III Patients |
|
|
| Recruiting | N/A | 240 | | astragalus decoction, valsartan ;valrtan,placebo | Shanghai Putuo District Central Hospital; Shanghai Putuo District Central Hospital, Shanghai Health Family Planning Committee “Three -Year Action Plan of Chinese Medicine Pharmaceutical Development in Shanghai” Project Number:ZY3-CCCX-3-3003 | Diabetic nephropathy | | | | |
ChiCTR-IOR-16010174: Clinical Study on Treatment of spleen and kidney Yang deficiency type of IgA nephropathy proteinuria with 'Huangqi guizhi wuwu' decoction |
|
|
| Recruiting | N/A | 100 | | Basic treatment+Valsartan Capsules treatment ;Basic treatment+Huangqi guizhi wuwu decoction treatment | Shuguang Hospital affliliated to Shanghai Univesrity of TCM; Shuguang Hospital affliliated with shanghai Univesrity of TCM, The municipal fiscal funds and unit self-raised funds | IgA nephropathy | | | | |
ChiCTR-INR-17011060: Shendi Granules on PBMC apoptosis and MCP-1, TGF- beta 1 in chronic glomerulonephritis patients with spleen and kidney deficiency syndrome |
|
|
| Not yet recruiting | N/A | 60 | | conventional therapy+Shendi Granules ;conventional therapy+Valsartan | the First Affiliated Hospital of Anhui University of Traditional Chinese Medicine; Level of the institution:, Self financing | Chronic glomerulonephritis | | | | |
| Recruiting | N/A | 72 | | Valsartan and Amlodipine Tablets (I) ;缬沙坦氨氯地平片(I) | West China Hospital, Sichuan University; West China Hospital, Sichuan University, independently | 高血压 | | | | |
ChiCTR-INR-17012070: Yongquan acupoint Shenque moxibustion curative effect of traditional Chinese medicine in the treatment of membranous nephropathy |
|
|
| Not yet recruiting | N/A | 150 | | Yongquan Shenque paste of Chinese medicine with mild moxibustion ;Valsartan Tablets | Shijiazhuang Nephropathy Hospital; Shijiazhuang Nephropathy Hospital, raise independently | Membranous nephropathy | | | | |
ChiCTR-OOD-17013741: Effect of fully blocking type 1 angiotensin receptor on blood pressure, cardiac structure, cardiac function and cognitive function in postmenopausal hypertensive women |
|
|
| Not yet recruiting | N/A | 98 | | Different doses of valsartan | Lanzhou University Second Hospital; Lanzhou University Second Hospital, Scientific research project of Gansu health industry | hypertension | | | | |
ChiCTR2000041383: Single-center, randomized open clinical trial of the clinical efficacy and safety of Sakubatravalsartan Sodium Tablets (Noxinto) 100mg, bid in the early application of PCI after acute myocardial infarction |
|
|
| Recruiting | N/A | 70 | | Valsartan ;Sacurbacter Valsartan | Department of Cardiology, Tangdu Hospital; Tangdu Hospital, Fourth Military Medical University, none | Acute myocardial infarction | | | | |
ChiCTR2000030912: Clinical observation of Dachaihu decoction in the treatment of Irascibility hyperactivity syndrome(overabundant liver-fire syndrom) of hypertension |
|
|
| Not yet recruiting | N/A | 194 | | Dachaihu soup granule formula ;Valsartan capsule | Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission | Essential hypertension | | | | |
ChiCTR2000031060: The Network Pharmacology and Mechanism Analysis of Xianxiong Chengqi Decoction in Treating Hypertension with Phlegm and Blood Stasis Syndrome |
|
|
| Not yet recruiting | N/A | 194 | | granules of xianxiongchengqi decoction ;Valsartan capsule | Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission | Essential hypertension | | | | |
ChiCTR2000031103: Clinical study and Mechanism of Huanglian jiedu decoction in the treatment of Hypertension with hyperactivity of liver fire Syndrome based on Network Pharmacology |
|
|
| Not yet recruiting | N/A | 194 | | granules of Huanglianjiedu decoction ;Valsartan capsule | Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission | Essential hypertension | | | | |
ChiCTR2000031117: A randomized controlled trial for the clinical effect of Wu-Mei-Wan Decoction in the treatment of primary hypertension with upper heat and lower cold syndrome |
|
|
| Not yet recruiting | N/A | 194 | | granules of ;Valsartan capsule | Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission | Essential hypertension | | | | |
ChiCTR2000031157: Mechanism and Clinical research of Zhenganxifeng dispensing granule decoction for treatment of hypertension with Yin Deficiency and Yang Hyperactivity Syndrome based on network pharmacology |
|
|
| Not yet recruiting | N/A | 194 | | Zhenganxifeng dispensing granule decoction ;Valsartan capsule | Affiliated Hospital of Shandong University of TCM; Affiliated Hospital of Shandong University of TCM, Shandong development and reform commission | Essential hypertension | | | | |
ChiCTR2000033890: Clinical efficacy evaluation of Qingda Granule in the treatment of hypertension (grade 1, low to medium-risk) patients: a multicenter, randomized, double-blind, double-simulated, parallel-controlled, non-inferiority clinical study |
|
|
| Recruiting | N/A | 552 | | Qingda granules + Valsartan capsule simulation agent: Qingda granules 1 bag/time, 2 times/day; Valsartan capsule analog, 1 capsule/day. ;Valsartan capsule + Qingda granules simulation agent: Qingda granules simulation agent 1 bag/time, 2 times/day; Valsartan capsule, 1 capsule/day. | Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences; Xiyuan Hospital, Chinese Academy of Chinese Medical Sciences, The management | hypertension | | | | |
ChiCTR1800020241: Investigation for Risk Factors of Membrane Nephropathy in Guangxi and Study for Intervention of Vitamin D |
|
|
| Recruiting | N/A | 120 | | Active Vitamin D 0.5ug/day ;Valsartan capsule 160mg/day ;Active vitamin D 0.5ug / day + valsartan capsule 160mg / day | The People's Hospital of Guangxi Zhuang Autonomous Region; The People's Hospital of Guangxi Zhuang Autonomous Region, Science and Technology Bureau of Qingxiu District, Nanning City, Guangxi Zhuang Autonomous Region | Idiopathic membranous nephropathy | | | | |
ChiCTR2000039700: A single center randomized controlled clinical study on the treatment of Children with Purpura nephritis with Huai-Qi-Huang Granules |
|
|
| Recruiting | N/A | 10 | | Huaiqihuang ;valsartan | Children's Hospital, Zhejiang University School of Medicine; Children's Hospital, Zhejiang University School of Medicine, Chen Xiaoping Foundation for the Development of Science and Technology of Hubei Province | Children with purpura nephritis | | | | |
| Not yet recruiting | N/A | 45 | | Tangshenkang + ACEI class of drugs (benazepril) ;ACEI (benazepril) + ARB drug (valsartan) ;ACEI class of drugs(benazepri) | Yangzhou University Medicine college; Yangzhou University Medicine college, Jiangsu Provincial Traditional Chinese Medicine Bureau Science and Technology Project Plan | Diabetic nephropathy | | | | |
ChiCTR1900026018: Wenshen-Huatan-Quyu particle combined with valsartan for benign hypertensive nephrosclerosis: a randomized controlled trial |
|
|
| Not yet recruiting | N/A | 70 | | Wenshen-Huatan-Quyu particle plus valsartan ;Wenshen-Huatan-Quyu placebo plus valsartan | Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine; Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai Science and Technology Commission Guiding Project (No. 19401943700) | Chironic kidney disease | | | | |
ChiCTR1800015179: Clinical effect of Mudan granule on diabetic microvascular complication. |
|
|
| Not yet recruiting | N/A | 1140 | | Diovan ;Mudan granule ;Diovan and Mudan granule ;Diovan ;Diovan ;Diovan and Mudan granule | Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University; Metabolic Diseases Hospital & Tianjin Institute of Endocrinology, Tianjin Medical University, None | diabetic microvascular complication | | | | |
ARNI-HD, ChiCTR2100042186: Application of sacubarb / valsartan in maintenance hemodialysis patients with preserved ejection fraction heart failure: a single arm study |
|
|
| Recruiting | N/A | 200 | | sacubarb/valsartan taken | Peking Union Medical College Hospital, Chinese Academy of Medical Sciences; Peking Union Medical College Hospital, raise the fund independently | End Stage Renal Disease, Heart Failure | | | | |
AWARD-HF2, ChiCTR1900028191: Withdrawal of Neprilysin Inhibition for heart failure in ARNI responders with recovered ischemic cardiomyopathy |
|
|
| Not yet recruiting | N/A | 50 | | continous administration ARNI ;stop ARNI, only taking Valsartan | Changzhou 2nd Hospital; Nanjing First Hospital, no sponsor | ischemic heart disease | | | | |
ChiCTR2200064406: Effect of sarcubitril valsartan in antihypertension and improvement of prognosis of cardiovascular diseases in patients on hemodialysis |
|
|
| Recruiting | N/A | 181 | | sarcubitril valsartan | Department of Nephrology Peking University First Hospital; Peking University First Hospital, Suzhou Industrial Park Xinxin Cardiovascular Health Foundation | N/A | | | | |
ChiCTR2100053690: Clinical efficacy of combining Huaiqihuang Granules with ARB in the treatment of chronic glomerulonephritis (Qi and Yin deficiency type)-a prospective randomized controlled study |
|
|
| Recruiting | N/A | 36 | | Valsartan Tablets combined with Huaiqihuang Granules ;Valsartan Tablets | the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine; the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Hubei Chen Xiaoping Science and Technology Development Foundation CXPJJH21002-202106 | Chronic glomerulonephritis | | | | |
ChiCTR2000035168: Evaluation The Influence of Duration after Sacubatril/valsartan Initiation on Short-term and Long-term Prognosis in Patients with Acute Heart Failure |
|
|
| Not yet recruiting | N/A | 800 | | ACEI/ARB ;Sacubatril/valsartan | Zhongshan Hospital Fudan University; Zhongshan Hospital Fudan University, Other | acute heart failure | | | | |
NCT06344247: Comparison of the Efficacy and Safety of SGLT2i and GLP-1 Receptor Agonists in Obese Patients With Kidney Disease |
|
|
| Recruiting | N/A | 48 | RoW | RAS inhibitors:Losartan®️/Valsartan®️, dapagliflozin:Forxiga®️, simagliptin:Forxiga®️, Semaglutide®️ | RenJi Hospital | Obesity, Chronic Kidney Diseases | 09/25 | 12/25 | | |
| Not yet recruiting | N/A | 63 | | Chuanhuang No.1 prescription+ Valsartan ;valsartan | Shanghai Dong Fang Hospital; Shanghai Dong Fang Hospital, self-raised | Primary IgA nephropathy | | | | |
ChiCTR2200056016: Evidence-based evaluation of Qidan Tangshen granule in the treatment of early diabetic kidney diease |
|
|
| Recruiting | N/A | 200 | | Qidan Tangshen granule, Valsartan simulator ;Qidan Tangshen granule simulator, Valsartan | LongHua Hospital Shanghai University of Traditional Chinese Medicine; LongHua Hospital Shanghai University of Traditional Chinese Medicine, Science & Technology Department of Shanghai | Type 2 diabetic nephropathy | | | | |
ChiCTR2200062663: A clinical study of traditional Chinese medicine combined with western medicine in treatment of primary IgA nephropathy (IgAN) in CKD stage 3 |
|
|
| Not yet recruiting | N/A | 63 | | oral valsartan ;Valsartan + Chuanhuang 1 prescription | Shanghai East Hospital (East Hospital Affiliated to Tongji University); Shanghai East Hospital (East Hospital Affiliated to Tongji University), Shanghai East Hospital (East Hospital Affiliated to Tongji University) | IgA nephropathy | | | | |
NCT05271448: Continuing or Discontinuing ACE/ARBs in Patients With Chronic Kidney Disease Undergoing Coronary Angiography |
|
|
| Recruiting | N/A | 600 | RoW | Continue ACEI or ARBs ( Enalapril , Ramipril , Valsartan , Candesartan, Losartan ), Continue ACEI or ARBs, Hold ACEI or ARBs | An-Najah National University | Contrast-induced Nephropathy, Chronic Kidney Diseases, Ischemic Heart Disease | 06/24 | 08/24 | | |
ChiCTR2300071967: Observation on the clinical efficacy of Shen Ge San combined with enhanced external counterpulsation in improving chronic heart failure |
|
|
| Recruiting | N/A | 108 | | On the basis of standard Western medicine treatment (valsartan 40/80mg qd po, spironolactone 20mg qd/bid po, metoprolol 12.5mg/25mg qd/bid po;) combined with EECP treatment, take Shen Ge San twice a day, 3g each time; ;On the basis of standard Western medicine treatment (valsartan 40/80mg qd po, spironolactone 20mg qd/bid po, metoprolol 12.5mg/25mg qd/bid po;) combined with EECP, take a placebo twice a day, 3g each time; | Shanghai Jing'an District Shibei Hospital ; Shanghai Jing'an District Shibei Hospital, Shanghai Municipal Health Commission | chronic heart failure | | | | |
ChiCTR2200065675: Clinical study on abdominal acupuncture in the treatment of heart and kidney yang deficiency syndrome of heart failure |
|
|
| Not yet recruiting | N/A | 84 | | Conventional drug therapy (valsartan + metoprolol succinate + spironolactone + Furosemide)+ abdominal acupuncture ;Conventional drug therapy (valsartan + metoprolol succinate + spironolactone + Furosemide) | Beijing Mentougou Hospital of Traditional Chinese Medicine; Beijing Mentougou Hospital of Traditional Chinese Medicine, Capital's Funds for Health Improvement and Research(2022-3-7061) | heart failure | | | | |
ChiCTR2300073557: Study on the effect of azilsartan on the early index of renal injury |
|
|
| Not yet recruiting | N/A | 900 | | Azithartan 20mg/d ;Valsartan 80mg/d | Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Hengxin Funding | Hypertensive nephropathy | | | | |
ChiCTR2300070218: Randomized controlled trial of Tangshenweining formula in treating diabetic nephropathy by improving vascular endothelial function |
|
|
| Recruiting | N/A | 64 | | Tangshenweining formula + valsartan ;Placebo + Valsartan | Beijing Chaoyang Hospital, Capital Medical University; Beijing Chaoyang Hospital, Capital Medical University, Capital's Funds for Health Improvement and Research, Beijing, China (No. CFH 2022-3-20311) | Diabetic nephropathy | | | | |
NCT03535376: Bariatric Surgery and Pharmacokinetics of Valsartan |
|
|
| Recruiting | N/A | 12 | Europe | Valsartan, Diovan, Kalpress, Tareg, Provas, Miten | Norwegian University of Science and Technology, St. Olavs Hospital, Volvat Medisinsk Senter Stokkan, Namsos Hospital, Alesund Hospital | Obesity, Morbid | 10/26 | 10/26 | | |
ChiCTR2000035619: A prospective, multicenter registration study to evaluate the coding, prognosis and intervention in patients of heart failure with preserved ejection fraction |
|
|
| Not yet recruiting | N/A | 615 | | Standard treatment for heart failure + Sacubatril valsartan ;Standard treatment for heart failure + Valsartan | Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Major clinical research project of Shanghai Shenkang Hospital Development Center | Heart Failure with Preserved Ejection Fraction | | | | |